CN103215236A - Dust mite allergens Derf8 and Derf20, and genes and applications thereof - Google Patents
Dust mite allergens Derf8 and Derf20, and genes and applications thereof Download PDFInfo
- Publication number
- CN103215236A CN103215236A CN201310033693XA CN201310033693A CN103215236A CN 103215236 A CN103215236 A CN 103215236A CN 201310033693X A CN201310033693X A CN 201310033693XA CN 201310033693 A CN201310033693 A CN 201310033693A CN 103215236 A CN103215236 A CN 103215236A
- Authority
- CN
- China
- Prior art keywords
- dust mite
- leu
- lys
- der
- asp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Landscapes
- Peptides Or Proteins (AREA)
Abstract
The invention relates to dust mite allergens Derf8 and Derf20, and genes and applications thereof, and belongs to the technical field of biomedicine. The dust mite allergens Derf8 and Derf20 are respectively composed of amino acid sequences represented by SEQ ID NO: 1 and SEQ ID NO: 3. The genes coding the dust mite allergens Derf8 and Derf20 are respectively composed of nucleotide sequences represented by SEQ ID NO: 2 and SEQ ID NO: 4. The invention also relates to applications of the dust mite allergens Derf8 and Derf20 in preparing medicines used for treating dust mite allergic diseases. The invention has the advantages that: the dust mite allergens Derf8 and Derf20 and the genes thereof are provided; and the applications of the dust mite allergens Derf8 and Derf20 in preparing medicines used for treating dust mite allergic diseases are provided.
Description
Technical field:
The present invention relates to a kind of dust mite allergen Der f 8 and Der f 20 and gene and application, belong to field of biomedicine technology.
Background technology:
Anaphylactic disease (as asthma, allergic rhinitis etc.) is common disease, frequently-occurring disease clinically, the total incidence of countries in the world anaphylactic disease is up to 10-30%, it is the great hygienic problems of our times, China has asthmatic patient more than 2,000 ten thousand now at present, Allergic Rhinitis more than 5,000 ten thousand, and its M & M is still in rising trend, recent two decades comes sickness rate almost to turn over one times.In causing numerous inhalant allergens of anaphylactic disease, the dirt mite is the most important factor that causes the allergic airway disease disease.Since Voorhorst and Spieksma(1964) confirm that first dirt mite and meta-bolites are the main allergen in room dirt since, countries in the world (American-European countries, Japan, China etc.) allergology worker also unanimously confirms that by a large amount of investigation the dirt mite is global main allergen.The dirt mite is the about 70-80% of positive rate in the immunodiagnosis of anaphylactic disease patient-specific.Since Noon and Freeman(1911) since first Application thimothy grass Pollen allergenic extract (allergen extract) is used for the treatment of pollinosis, desensitization treatment is the history of existing more than 90 year so far.Along with the further understanding to the pathogenetic further investigation of allergic disease and immunotherapy mechanism, WHO(1997) suggestion renames as allergen vaccine (allergen vaccine) by allergenic extract, and points out in " policy paper of the relevant immunotherapy of WHO " (1998): (1) encourages the standardized allergen vaccine of application and development; (2) high-quality allergen vaccine is depended in successful immunotherapy.Therefore, develop the efficient allergen vaccine of a new generation and be still this area research focus both at home and abroad.
Because the dirt mite is the medical science arthropods, structure and complicated, although at present people in the hundreds of albumen of dirt mite preliminary evaluation go out 16 kinds of anaphylactogen compositions, studies show that the anaphylactogen much more than 30 that the dirt mite contains plants.With regard to some dust mite allergy patients, he may only produce anaphylaxis to the class in the dirt mite or number class allergen protein.And for dust mite allergy patient diagnosis and desensitization treatment, be at present still the thick immersion liquid of dirt mite clinically, wherein contain in a large number the non-specific anaphylactogen of patient and other impurity, this has seriously hindered the standardized formulation of dust mite allergy original reagent and use clinically thereof.So further verify the definite component of dust mite allergen, will bring for the dust mite allergy patient desensitization treatment of individuation.
Summary of the invention:
The object of the present invention is to provide a kind of dust mite allergen Der f 8 and Der f 20 and gene and application.
Technical scheme of the present invention is as follows:
Der f 8 is that we identify a kind of new allergen protein obtained first from the homogenate of dirt mite, and it belongs to glutathione transferring enzyme family (Glutathione S-transferase), and molecular weight is 32 kDa approximately.Der f 8 is comprised of 197 amino acid, its aminoacid sequence following (SEQ ID NO:1):
MLAYAGVDYVDKRYNIGPNFDRSEWLNEKFNLGLDFPNLPYYMDGDVKITQSMAILRYLA 60
RKYNMDGTNEQERLRISMAEQQTHDMFMAMVRICYDPNMENLRVDYLKTLPDSLKLMEKF 120
LANHDYIAGSKISYADFYLYEYLCRMKVMVPEVYGQFENLKKFVERIESLPRIAEYIKKQ 180
KPTTFNASLAKWNGSYA 197
Dust mite allergen Der f 8 gene clone steps comprise: the total RNA of dirt mite extracts, the mRNA purifying, and mRNA reverse transcription and cDNA library build, and the design primer, utilize PCR method amplification coding gene.The gene sequencing result shows that the encoding gene (GenBank accession KC305499) of dust mite allergen Der f 8 is comprised of 595 Nucleotide, and 5 ' end to 3 ' terminal sequence of this gene is (nucleotides sequence is classified SEQ ID NO:3 as):
atgttggcat atgccggtgt tgattatgtt gataaacgtt ataatattgg tccgaatttt 1
gatcgttcag aatggttgaa tgaaaaattc aatttgggtt tagatttccc aaatttgcca 61
tattacatgg atggtgatgt taaaattacc caatcgatgg ccattcttcg ttatttggcc 121
cgtaaatata acatggatgg tactaatgaa caggaacgtt tacgaatttc aatggctgaa 181
caacaaacac atgatatgtt tatggccatg gtccgtattt gttatgatcc aaatatggaa 241
aacttacgag ttgattattt gaaaacattg cccgattcat tgaaattgat ggaaaaattt 301
ttagctaatc atgattatat tgccggttca aaaatttctt atgcagattt ttatttgtat 361
gaatatttgt gccgtatgaa agtcatggta ccagaagtat atggacaatt tgaaaatttg 421
aaaaaatttg ttgaacgcat tgaatcattg ccacgtattg ccgaatacat taagaaacaa 481
aaaccaacaa cattcaatgc atcattggct aaatggaatg gttcttatgc ctaa 595
Der f 20 belongs to a class arginine kinase (Arginine kinase), and molecular weight is 40 kDa approximately.Der f 20 is comprised of 356 amino acid, its aminoacid sequence following (SEQ ID NO:2):
MVDQATLSKLEAGFQKLQNAQDCHSLLKKYLTRDVLDQLKTKKTDMGATLLDVIQSGVEN 60
LDSGVGIYAPDAQSYKTFAALFDPIIDDYHKGFKPTDKHPQTDFGNIEHFVNVDPKNEYV 120
ISTRVRCGRSLKGYPFNPMLTEAQYKEMETKVKGQLATFEGELKGTYYPLLGMDKATQQK 180
LIDDHFLFKEGDRFLQAANACRYWPVGRGIFHNDKKTFLMWVNEEDHLRIISMQKGGDLK 240
EVFGRLVKAVKHIEQKIPFSRDDRLGYLTFCPTNLGTTIRASVHIKLPKLAADRKKLEEV 300
AARYNLQVRGTAGEHTESVGGIYDISNKRRMGLTEYQAVKEMQDGIIELIKMEKSL 356
Dust mite allergen Der f 20 gene clone steps comprise: the total RNA of dirt mite extracts, the mRNA purifying, and mRNA reverse transcription and cDNA library build, and the design primer, utilize PCR method amplification coding gene.The gene sequencing result shows that the encoding gene (GenBank accession EU106619.1) of dust mite allergen Der f 20 is comprised of 1071 Nucleotide, and 5 ' end to 3 ' terminal sequence of this gene is (nucleotides sequence is classified SEQ ID NO:4 as):
atggtcgatc aagctaccct gagtaaattg gaagccggtt tccaaaaatt acagaatgct 60
caagattgtc attcattgtt gaaaaagtat ttgactcgcg atgtgttaga tcaactcaag 120
acgaaaaaga ccgacatggg cgcaacatta ttggatgtta tccaatctgg cgtggaaaac 180
ctggacagtg gtgttggtat ctatgctcct gatgctcaat catacaaaac atttgctgca 240
ttgttcgatc caatcattga tgattaccat aaaggcttca aaccgaccga taaacatccg 300
caaactgatt tcggcaatat cgaacacttt gtcaatgttg atcctaaaaa cgaatacgtc 360
atttctactc gtgttcgatg tggccgttcg ttgaaaggct atccattcaa ccctatgttg 420
acagaggctc aatacaaaga aatggaaacc aaagtgaaag gacaattggc cacattcgaa 480
ggcgaattga aaggcaccta ttacccattg ttgggaatgg ataaagctac tcaacagaaa 540
ttgatcgacg atcatttctt gttcaaggaa ggtgatcgat tcttgcaagc tgccaatgca 600
tgtcgttact ggcctgttgg tcgtggtatc ttccacaatg acaaaaaaac attcttgatg 660
tgggtaaacg aagaagatca tttgcgtatc atttccatgc aaaaaggtgg cgatctaaaa 720
gaggtctttg gacgtttggt caaggctgtc aagcacattg aacaaaagat tccattctct 780
cgtgatgacc gtctcggtta tttgacattc tgtccaacca atcttggcac aaccatccgt 840
gcttcggttc atatcaaact tccgaaattg gccgctgacc gtaagaagtt ggaagaagtg 900
gctgctcgtt acaatcttca agtgcgtggc actgcaggtg aacataccga aagtgtgggt 960
ggtatctatg atattagtaa caaacgacga atgggtctca ccgaatacca agctgttaa1020
gaaatgcaag atggcatcat tgaattgatt aaaatggaaa aatcattgta a 1071
Detect by conventional two-dimensional electrophoresis and two-way Western blot method, find that Der f 8 and Der f 20 have stronger allergenicity, the application in preparation treatment dust mite allergy disease medicament.
Beneficial effect of the present invention is: dust mite allergen Der f 8 and Der f 20 and gene thereof are provided, and dust mite allergen Der f 8 and Der f 20 can be as the application of preparation treatment dust mite allergy disease medicament.
The accompanying drawing explanation:
Fig. 1. be the peak type figure that molecular sieve Sephadex-G75 is crossed in the homogenate of dirt mite.
The Westernblot that Fig. 2 is dirt mite homogenate Sephadex-G75 II peak, wherein: put 1 Der f 20, put 2 and 3 for Der f 8.
Fig. 3-A to Fig. 3-E is the ESI-Q-TOF mass spectrum.Wherein: the mass spectrum that Fig. 3-A to Fig. 3-B is Der f 8; The mass spectrum that Fig. 3-C to Fig. 3-E is Der f 20
Embodiment:
Embodiment mono-: the evaluation of dust mite allergen and determined amino acid sequence thereof
One, the preparation of the raising of dirt mite and collection and the homogenate of dirt mite
The dust mite of pure strain is carried out to batch as for the mouse grain that adopts the grinds powder under the condition of 25 ℃ of relative humidity 75% raises.Because the dirt mite has the life characteristic of lucifuge, the available incandescent lamp luminescence method is separated the dirt mite from feed.For the dirt mite separated, can add appropriate 20mM pH 7.8 Tris-HCL fully to grind, then at centrifugal 30 min of rotating speed 12000 * g, obtain supernatant.
Two, the separation and purification of dirt mite homogenate and two-dimensional electrophoresis and Western blot thereof detect
The supernatant liquor of above-mentioned collection of take is raw material, is splined on and uses in advance the good molecular sieve gel chromatography Sephadex-G75 of 20mM pH7.8 Tris-HCL damping fluid balance, with identical damping fluid, carries out wash-out.Flow velocity is 0.3ml/min, with the every 10min of automatic collector, collects a pipe, detects the absorption value of every pipe at 280nm and 215nm place, makes the peak type figure of absorption value variation as shown in Figure 1.Then every peak is collected to freeze-drying and concentrated separation and purification or two-dimensional electrophoresis and the Western blot detection thereof for next step.Two-dimensional electrophoresis and Western blot concrete steps thereof are as follows:
A. sample preparation: adopt the 2D clean-up of GE company the sample from each peak of molecular sieve to be carried out to the processing such as desalination and concentration, main process is as follows:
1: in will the micro centrifugal pipe of sample as for 1.5 ml containing the 60 μ g 100 μ l that have an appointment, add 300 μ l precipitation agents vibrations to stir evenly, ice bath 15 min.
2: with centrifugal 5 min of maximum speed of revolution (12000 * g), get clean supernatant as far as possible.Add 40 μ l coprecipitators, ice bath 5 min.Centrifugal 5 min of same rotational speed, remove supernatant with liquid-transfering gun again, adds 25 μ l to add 1 ml lavation buffer solution (-20 ℃ of at least precoolings 1 hour) and 5 μ l detergent additives, vibration until precipitation scatter fully.Pipe is hatched under-20 ℃ at least 30 min, every 10 min vibration 20 to 30 s.
3: with centrifugal 5 min of rotating speed 12000 * g.
4: carefully supernatant is removed, now visible white precipitate, will precipitate simply air-dry.
5: add 150 μ l hydrating fluids dissolution precipitation again, use to isoelectric focusing electrophoresis (IEF) in order to first.
B. isoelectrofocusing (IEF): will be splined on the non-linear adhesive tape of the long Immobiline DryStrip of 7 cm containing the 60 μ g sample 100 μ l hydrating fluids of having an appointment, on Ettan IPGphor III isoelectrofocusing system, focus on, the isoelectrofocusing condition is 20 ℃, the electric current of every glue is 50 μ A, and gross focusing volt hour is about 6 kVh.The adhesive tape that isoelectrofocusing is good is respectively washed 15 min with the balance liquid that contains dithiothreitol (DTT) (DTT) and iodo-acid amide respectively, on the SDS-PAGE glue face that the concentration that good adhesive tape is disposed across to prepare by balance is 12%, and seals with agarose, prepares second to electrophoresis.
C. second to electrophoresis: for the glue width, only have the blob of viscose of 7 cm to be run glue with SE260.In the condition of 20 mA/ glue, get final product next half an hour.
Embodiment bis-: the gene clone of dust mite allergen
One, the total RNA of dirt mite extracts
A. take the approximately dirt mite alive of 80 mg, add 1 mL Trizol extracting solution (American I nvitrogen company) of precooling, and add the abundant homogenate of liquid nitrogen.
B. the chloroform that adds Trizol 1/5 volume, acutely mix approximately 15 seconds, and room temperature is placed 5 minutes, and 4 ℃, centrifugal 10 minutes of 12000 rpm, get supernatant.
C. supernatant adds isopyknic Virahol, and room temperature is placed 10 minutes, and 4 ℃, centrifugal 10 minutes of 12000 rpm, precipitation is washed once with 75% ethanol, dries, and pipe end throw out is the total RNA of intestines in the Eupolyphaga Seu Steleophaga digestive tube.
Two, the purifying of dirt mite mRNA
Dirt mite mRNA separation and purification adopts the PolyATtract of U.S. PROMEGA company
mRNA Isolation Systems test kit.
A. get the total RNA 500 μ g of dirt mite and be dissolved in 500 μ L DEPC water, 65 ℃ of water-bath 10 min, add Oligo (dT) probe and the 13 μ L 20 * SSC solution of people 3 μ L, mixes, and places room temperature cooling, is called A liquid.
B. the washing of magnetic bead (SA-PMP): magnetic bead is flicked and mixes, to magnetic frame absorption 30 seconds, abandon supernatant, add 0. 5 * SSC, 300 μ L, to magnetic frame absorption 30 seconds, finally add 100 μ L 0. 5 * SSC and suspend, be called B liquid.
C. A liquid is added in B liquid, room temperature was placed 10 min, to magnetic frame absorption 30 seconds, abandon supernatant, with 0. 1 * SSC washing 4 times, finally abandon supernatant, add 100 μ L DEPC aqueous suspensions, adsorb 30 s to magnetic frame, supernatant is moved to new test tube, then add 150 μ L DEPC water resuspended, adsorb 30 s to magnetic frame, move supernatant to above-mentioned test tube, be intestines mRNA in the Eupolyphaga Seu Steleophaga digestive tube of purifying.
D. the sodium acetate solution that adds pH5. 2,3 M of 1/10 volume, the equal-volume Virahol, in-70 ℃ of placements 30 minutes, 4 ℃, centrifugal 10 min of 12000 rpm, abandoned supernatant, is precipitated and dissolved in 10 μ L DEPC water.
Three, dirt mite cDNA library builds
Adopt the Creator of CLONTECH company
tMsMART
tMcDNA Library Construction Kit builds dirt mite cDNA library.
A. cDNA the first chain is synthetic
Add 2 μ l dirt mite mRNA, 1 μ l SMART IV primer, 1 μ l CDS III/3 ' PCR primer, 1 μ l RNA-free water in aseptic PCR pipe, make cumulative volume reach 5 μ l, mix also of short duration centrifugal.
1.72 ℃ insulation 2 min, hatch 2 min on ice.
2. add 2 μ l 5 * the first chain buffer, 1 μ l 20 mmol/L DTT, 1 μ l 10 mmol/L dNTP mixtures, 1 μ l PowerScript reversed transcriptive enzyme in above-mentioned PCR pipe, mix also of short duration centrifugal.
3., after being placed in 42 ℃ of insulation 1 hr of PCR instrument, ice bath stops the synthetic of the first chain.
B. adopt long end polymerase chain reaction (LD-PCR) method amplification cDNA the second chain
1. 1 μ l cDNA the first chain, 40 μ l deionized waters, 5 μ l 10 * Advantage 2 PCR damping fluids, 1 μ l 50 * dNTP mixture, 1 μ l 5 ' PCR primer, 1 μ l CDS III/3 ' PCR primer and 1 μ l polysaccharase are mixed in the PCR pipe.
2. in the PCR instrument, by following program, increase: 95 ℃, 20 sec; 22 circulations: 95 ℃, 5 sec; 68 ℃, 6 min.
3., after amplification finishes, synthetic double-stranded cDNA is placed in to-70 ℃ of preservations.
C. the conversion that enzyme is cut, connected and connects product:
1. add 1 μ L pMD19-T carrier (Japanese Takara company), the double-stranded solution of 4 μ L dirt mite cDNA in Eppendorf tube, full dose is 5 μ L.
2. add 5 μ L(equivalent) the ligase enzyme buffer mixture.
3. 16 ℃ are reacted 2 hours.
4. full dose (10 μ L) is added in 100 μ L DH5 α competent cells (sky, Beijing root biochemical technology company limited), ice bath 30 minutes.
5. after 42 ℃ of 90 seconds of heating, then in ice, place 1 minute.
6. add 37 ℃ of LB substratum 900 μ L of bathing of temperature, 37 ℃ of slow shaking culture 60 minutes.
7. get 200 μ L and coat on the LB substratum that contains X-Gal, IPTG, Amp 37 ℃ and cultivate 16 hours, form single bacterium colony.
8. 5 mL LB liquid nutrient medium washing bacterium colonies for each LB plate, add 30% glycerine frozen.The cDNA built is approximately containing 2 * 10
6individual independent clone.
Four, the amplification of dust mite allergen gene order and mensuration:
Aminoacid sequence according to separation and purification gained dust mite allergen Der f 8 in embodiment mono-, we have designed a degenerated primer Der f 8-F and Der f 20-F, joint primer CDS III/3 ' the PCR pairing of using when building intestines cDNA library in the Eupolyphaga Seu Steleophaga digestive tube, forward and reverse primer sequence is:
CDS III/3’ PCR:5’-ATT CTA GAG GCC GAG GCG GCC ATG-3’
Der f 8-F: 5’-ATGCT(A/T/C/G)GC(A/T/C/G)TA(T/C)GC(A/T/C/G)GG(A/T/C/G)
GT(A/T/C/G)GA(T/C)-3’
Der f 20-F: ’-GG(A/T/C/G)GG(A/T/C/G)GA(T/C)CT(A/T/C/G)AA(A/G)GA(A/G)
GT(A/T/C/G)TT(T/C)GG(A/T/C/G)-3’
Wherein, the base in bracket means degenerated primer.
Degenerated primer Der f 8-F and joint primer CDS III/3 ' PCR pairing are used, and the dirt mite cDNA of take is template, carries out PCR.Its reaction conditions is: 95 ℃ of denaturation 4 min, then carry out 35 in following condition and take turns circulation, 94 ℃ of 30 sec, 55 ℃ of 30 sec, 72 ℃ of 40 sec, then 72 ℃ of 10 min.Then the PCR product is connected on the T carrier, imports bacillus coli DH 5 alpha, the screening mono-clonal is checked order.Result show the to encode cDNA sequence of allergen Der f 8 is comprised of 595 Nucleotide, and the cDNA sequence of coding allergen Der f 20 is comprised of 891 Nucleotide.
Embodiment tri-: the allergenicity of dust mite allergen Der f 8 and Der f 20 detects
Need to run two two-dimensional electrophoresis for the same sample in example one, wherein one for substantive dyeing, and one is then used in Western blot and detects its sensitization, and detailed process is as follows:
1: transferring film: the albumen on 2-D-SDS-PAGE glue is gone on pvdf membrane under the condition of 200 mA 2 h with the transferring film groove.
2: sealing: will turn the pvdf membrane that albumen is arranged and seal 2h with 5% skim-milk at normal temperature.
3: primary antibodie is hatched: the pvdf membrane sealed is washed with PBS, primary antibodie (dust mite allergy patients serum) is pressed to the 1:20 dilution with 5% skim-milk, 4 ℃ of overnight incubation.
4: two anti-hatching: the pvdf membrane that primary antibodie is hatched with the PBS washing, is pressed the 1:2000 dilution to two anti-(sheep anti human IgEs) with 5% skim-milk again, at normal temperature, hatches 1 hour.
5: develop: by two PBS washings 3 times for anti-pvdf membrane of hatching, each 5 min, add two appropriate anti-special luminous substrate on the film surface, with film, developed.
E. will mate 2-D-PAGE protein site preferably with development point on film and carry out the order-checking of ESI-Q-TOF mass spectrum.
Result is as shown in Fig. 2-B, and its mid point 1 Der f 20, put 2 and 3 for Der f 8.
SEQUENCE LISTING
<110 > Kunming Institute of Zoology, Chinese Academy of Sciences
<120 > dust mite allergen Der f 8 and Der f 20 and gene and application
<130> 1
<160> 4
<170> PatentIn version 3.3
<210> 1
<211> 197
<212> PRT
<213> Dermatophagoides farinae
<400> 1
Met Leu Ala Tyr Ala Gly Val Asp Tyr Val Asp Lys Arg Tyr Asn Ile
1 5 10 15
Gly Pro Asn Phe Asp Arg Ser Glu Trp Leu Asn Glu Lys Phe Asn Leu
20 25 30
Gly Leu Asp Phe Pro Asn Leu Pro Tyr Tyr Met Asp Gly Asp Val Lys
35 40 45
Ile Thr Gln Ser Met Ala Ile Leu Arg Tyr Leu Ala Arg Lys Tyr Asn
50 55 60
Met Asp Gly Thr Asn Glu Gln Glu Arg Leu Arg Ile Ser Met Ala Glu
65 70 75 80
Gln Gln Thr His Asp Met Phe Met Ala Met Val Arg Ile Cys Tyr Asp
85 90 95
Pro Asn Met Glu Asn Leu Arg Val Asp Tyr Leu Lys Thr Leu Pro Asp
100 105 110
Ser Leu Lys Leu Met Glu Lys Phe Leu Ala Asn His Asp Tyr Ile Ala
115 120 125
Gly Ser Lys Ile Ser Tyr Ala Asp Phe Tyr Leu Tyr Glu Tyr Leu Cys
130 135 140
Arg Met Lys Val Met Val Pro Glu Val Tyr Gly Gln Phe Glu Asn Leu
145 150 155 160
Lys Lys Phe Val Glu Arg Ile Glu Ser Leu Pro Arg Ile Ala Glu Tyr
165 170 175
Ile Lys Lys Gln Lys Pro Thr Thr Phe Asn Ala Ser Leu Ala Lys Trp
180 185 190
Asn Gly Ser Tyr Ala
195
<210> 2
<211> 594
<212> DNA
<213> Dermatophagoides farinae
<400> 2
atgttggcat atgccggtgt tgattatgtt gataaacgtt ataatattgg tccgaatttt 60
gatcgttcag aatggttgaa tgaaaaattc aatttgggtt tagatttccc aaatttgcca 120
tattacatgg atggtgatgt taaaattacc caatcgatgg ccattcttcg ttatttggcc 180
cgtaaatata acatggatgg tactaatgaa caggaacgtt tacgaatttc aatggctgaa 240
caacaaacac atgatatgtt tatggccatg gtccgtattt gttatgatcc aaatatggaa 300
aacttacgag ttgattattt gaaaacattg cccgattcat tgaaattgat ggaaaaattt 360
ttagctaatc atgattatat tgccggttca aaaatttctt atgcagattt ttatttgtat 420
gaatatttgt gccgtatgaa agtcatggta ccagaagtat atggacaatt tgaaaatttg 480
aaaaaatttg ttgaacgcat tgaatcattg ccacgtattg ccgaatacat taagaaacaa 540
aaaccaacaa cattcaatgc atcattggct aaatggaatg gttcttatgc ctaa 594
<210> 3
<211> 356
<212> PRT
<213> Dermatophagoides farinae
<400> 3
Met Val Asp Gln Ala Thr Leu Ser Lys Leu Glu Ala Gly Phe Gln Lys
1 5 10 15
Leu Gln Asn Ala Gln Asp Cys His Ser Leu Leu Lys Lys Tyr Leu Thr
20 25 30
Arg Asp Val Leu Asp Gln Leu Lys Thr Lys Lys Thr Asp Met Gly Ala
35 40 45
Thr Leu Leu Asp Val Ile Gln Ser Gly Val Glu Asn Leu Asp Ser Gly
50 55 60
Val Gly Ile Tyr Ala Pro Asp Ala Gln Ser Tyr Lys Thr Phe Ala Ala
65 70 75 80
Leu Phe Asp Pro Ile Ile Asp Asp Tyr His Lys Gly Phe Lys Pro Thr
85 90 95
Asp Lys His Pro Gln Thr Asp Phe Gly Asn Ile Glu His Phe Val Asn
100 105 110
Val Asp Pro Lys Asn Glu Tyr Val Ile Ser Thr Arg Val Arg Cys Gly
115 120 125
Arg Ser Leu Lys Gly Tyr Pro Phe Asn Pro Met Leu Thr Glu Ala Gln
130 135 140
Tyr Lys Glu Met Glu Thr Lys Val Lys Gly Gln Leu Ala Thr Phe Glu
145 150 155 160
Gly Glu Leu Lys Gly Thr Tyr Tyr Pro Leu Leu Gly Met Asp Lys Ala
165 170 175
Thr Gln Gln Lys Leu Ile Asp Asp His Phe Leu Phe Lys Glu Gly Asp
180 185 190
Arg Phe Leu Gln Ala Ala Asn Ala Cys Arg Tyr Trp Pro Val Gly Arg
195 200 205
Gly Ile Phe His Asn Asp Lys Lys Thr Phe Leu Met Trp Val Asn Glu
210 215 220
Glu Asp His Leu Arg Ile Ile Ser Met Gln Lys Gly Gly Asp Leu Lys
225 230 235 240
Glu Val Phe Gly Arg Leu Val Lys Ala Val Lys His Ile Glu Gln Lys
245 250 255
Ile Pro Phe Ser Arg Asp Asp Arg Leu Gly Tyr Leu Thr Phe Cys Pro
260 265 270
Thr Asn Leu Gly Thr Thr Ile Arg Ala Ser Val His Ile Lys Leu Pro
275 280 285
Lys Leu Ala Ala Asp Arg Lys Lys Leu Glu Glu Val Ala Ala Arg Tyr
290 295 300
Asn Leu Gln Val Arg Gly Thr Ala Gly Glu His Thr Glu Ser Val Gly
305 310 315 320
Gly Ile Tyr Asp Ile Ser Asn Lys Arg Arg Met Gly Leu Thr Glu Tyr
325 330 335
Gln Ala Val Lys Glu Met Gln Asp Gly Ile Ile Glu Leu Ile Lys Met
340 345 350
Glu Lys Ser Leu
355
<210> 4
<211> 1071
<212> DNA
<213> Dermatophagoides farinae
<400> 4
atggtcgatc aagctaccct gagtaaattg gaagccggtt tccaaaaatt acagaatgct 60
caagattgtc attcattgtt gaaaaagtat ttgactcgcg atgtgttaga tcaactcaag 120
acgaaaaaga ccgacatggg cgcaacatta ttggatgtta tccaatctgg cgtggaaaac 180
ctggacagtg gtgttggtat ctatgctcct gatgctcaat catacaaaac atttgctgca 240
ttgttcgatc caatcattga tgattaccat aaaggcttca aaccgaccga taaacatccg 300
caaactgatt tcggcaatat cgaacacttt gtcaatgttg atcctaaaaa cgaatacgtc 360
atttctactc gtgttcgatg tggccgttcg ttgaaaggct atccattcaa ccctatgttg 420
acagaggctc aatacaaaga aatggaaacc aaagtgaaag gacaattggc cacattcgaa 480
ggcgaattga aaggcaccta ttacccattg ttgggaatgg ataaagctac tcaacagaaa 540
ttgatcgacg atcatttctt gttcaaggaa ggtgatcgat tcttgcaagc tgccaatgca 600
tgtcgttact ggcctgttgg tcgtggtatc ttccacaatg acaaaaaaac attcttgatg 660
tgggtaaacg aagaagatca tttgcgtatc atttccatgc aaaaaggtgg cgatctaaaa 720
gaggtctttg gacgtttggt caaggctgtc aagcacattg aacaaaagat tccattctct 780
cgtgatgacc gtctcggtta tttgacattc tgtccaacca atcttggcac aaccatccgt 840
gcttcggttc atatcaaact tccgaaattg gccgctgacc gtaagaagtt ggaagaagtg 900
gctgctcgtt acaatcttca agtgcgtggc actgcaggtg aacataccga aagtgtgggt 960
ggtatctatg atattagtaa caaacgacga atgggtctca ccgaatacca agctgttaag 1020
gaaatgcaag atggcatcat tgaattgatt aaaatggaaa aatcattgta a 1071
Claims (3)
- Dust mite allergen Derf 8 and Der f 20, it is characterized in that by the aminoacid sequence shown in SEQ ID NO:1 and SEQ ID NO:3, being formed respectively.
- 2. the gene of coding dust mite allergen Der f 8 and Der f 20, is characterized in that the nucleotide sequence shown in SEQ ID NO:2 and SEQ ID NO:4, consisting of respectively.
- 3. dust mite allergen Der f 8 claimed in claim 1 and Der f 20 application in preparation treatment dust mite allergy disease medicament.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310033693XA CN103215236A (en) | 2013-01-29 | 2013-01-29 | Dust mite allergens Derf8 and Derf20, and genes and applications thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310033693XA CN103215236A (en) | 2013-01-29 | 2013-01-29 | Dust mite allergens Derf8 and Derf20, and genes and applications thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103215236A true CN103215236A (en) | 2013-07-24 |
Family
ID=48813398
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310033693XA Pending CN103215236A (en) | 2013-01-29 | 2013-01-29 | Dust mite allergens Derf8 and Derf20, and genes and applications thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103215236A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101816787A (en) * | 2002-11-26 | 2010-09-01 | 阿尔克-阿贝洛有限公司 | Allergen dosage form |
-
2013
- 2013-01-29 CN CN201310033693XA patent/CN103215236A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101816787A (en) * | 2002-11-26 | 2010-09-01 | 阿尔克-阿贝洛有限公司 | Allergen dosage form |
Non-Patent Citations (2)
Title |
---|
GENBANK: AGC56215.1: "glutathione S-transferase, partial [Dermatophagoides farinae]", 《GENEBANK》, 21 January 2013 (2013-01-21) * |
GENBANK: KC305499.1: "Dermatophagoides farinae glutathione S-transferase mRNA, partial cds", 《GENEBANK》, 21 January 2013 (2013-01-21) * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6068544B2 (en) | Hypoallergenic hybrid protein of major group 1 mite allergen and major group 2 mite allergen for use in the treatment of allergies | |
AU2009309477B2 (en) | Leukolectins and uses thereof | |
CN106967696B (en) | Allergen of artemisia pollen and application thereof | |
CN108484747B (en) | Japan frog skin repair peptide cathelicidin-NV and its gene and application | |
DK2563806T3 (en) | Human leukolectiner and uses thereof | |
CN110090295A (en) | Purposes of the Ephrin-B1 in the drug of preparation treatment inflammatory bowel disease | |
CN103073636A (en) | Dermtophagoides farinae allergens Der f 29 and Der f 30, and genes and applications thereof | |
CN102071184B (en) | Tabanusyao Macquart antithrombotic enzyme tablysin and gene and application thereof | |
CN103215236A (en) | Dust mite allergens Derf8 and Derf20, and genes and applications thereof | |
AU697491B2 (en) | Nucleic acids encoding a house dust mite allergen, Der p III, and uses therefor | |
CN103059119A (en) | Dust mite allergen Derf28 and genes and application thereof | |
CN103059120A (en) | Dust mite allergens Derf26 and Derf27 and genes and application thereof | |
CN103214565A (en) | Dust mite allergens Derf24 and Derf25, and genes and applications thereof | |
CN109134638A (en) | A kind of 22 gene recombinant protein of house dust mite allergen Der p and its application | |
CN101220089A (en) | Chinese South China sea signal conus neurotoxin gene Lt3.1 and uses thereof | |
WO2016088765A1 (en) | Novel dermatophagoides farinae protein | |
CN106620651A (en) | Application of heat shock protein gp96 in therapy of ulcerative colitis | |
CN104725499B (en) | Application of the Shelled Turtle Trionyx Sinensis Cathelicidin-Ps CATH4 peptides in anti-inflammatory medicaments are prepared | |
CN103755797B (en) | Antimicrobial peptide BG-CATH6 (5-29) of Bufo bufo gargarizans as well as encoding genes and application of antimicrobial peptide BG-CATH6 (5-29) of Bufo bufo gargarizans | |
JP5937970B2 (en) | New cypress pollen allergen | |
CN103705920B (en) | Kytoplasm Polyadenylation component binding protein 4 vaccine and Synthesis and applications thereof | |
ES2291648T3 (en) | ALLERGEN OF THE POLEM OF THE ARTEMISA. | |
CN106366178A (en) | Carcino-embryonic antigen immunogen polypeptide and application thereof | |
CN102121012A (en) | Dog B lymphocyte activating factor cDNA, cloning method and recombination application thereof | |
ES2349246T3 (en) | NOVEDOUS POLEN ALLERGEN. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130724 |